Name | 1,4-Bis(3-aminopropyl)piperazine |
---|---|
Synonyms |
MFCD00006161
1,4-Piperazinedipropanamine 3,3'-(1,4-Piperazinediyl)di(1-propanamine) EINECS 230-589-1 1,4-Bis(3-aminopropyl)piperazine 3,3'-PIPERAZINE-1,4-DIYLDIPROPAN-1-AMINE BAPPRZ BIS AMINOPROPYL PIPIRAZINE |
Density | 1.0±0.1 g/cm3 |
---|---|
Boiling Point | 334.5±0.0 °C at 760 mmHg |
Melting Point | 15 °C(lit.) |
Molecular Formula | C10H24N4 |
Molecular Weight | 200.324 |
Flash Point | 162.8±0.0 °C |
Exact Mass | 200.200104 |
PSA | 58.52000 |
LogP | -1.43 |
Vapour density | 6.9 (vs air) |
Vapour Pressure | 0.0±0.7 mmHg at 25°C |
Index of Refraction | 1.505 |
Symbol |
GHS05 |
---|---|
Signal Word | Danger |
Hazard Statements | H314 |
Precautionary Statements | P280-P305 + P351 + P338-P310 |
Personal Protective Equipment | Faceshields;full-face respirator (US);Gloves;Goggles;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter |
Hazard Codes | C:Corrosive; |
Risk Phrases | R34 |
Safety Phrases | S26-S27-S28-S36/37/39-S45 |
RIDADR | UN 2735 8/PG 2 |
WGK Germany | 3 |
RTECS | TK8700000 |
Packaging Group | II |
Hazard Class | 8 |
HS Code | 2933599090 |
~10% 7209-38-3 |
Literature: ARGENTA DISCOVERY LTD Patent: WO2006/82412 A2, 2006 ; Location in patent: Page/Page column 78 ; WO 2006/082412 A2 |
~97% 7209-38-3 |
Literature: Sogang University Research Foundation; HUR, Nam Hwi; LEE, Byeong No Patent: US2014/51858 A1, 2014 ; Location in patent: Paragraph 0081-0082 ; |
~% 7209-38-3 |
Literature: Journal of the American Chemical Society, , vol. 68, p. 1296 |
~% 7209-38-3 |
Literature: Journal of the American Chemical Society, , vol. 68, p. 1296 |
~79% 7209-38-3 |
Literature: Bernard, Helene; Del Rio Garcia, Eugenia; Ferec, Sonia; Kervarec, Nelly; Handel, Henri European Journal of Organic Chemistry, 2003 , # 2 p. 255 - 258 |
~% 7209-38-3 |
Literature: European Journal of Organic Chemistry, , # 6 p. 1050 - 1055 |
Precursor 5 | |
---|---|
DownStream 5 | |
HS Code | 2933599090 |
---|---|
Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |